Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OCGN | Common Stock | Options Exercise | $2.3K | +4.5K | $0.51 | 4.5K | Oct 6, 2022 | Direct | ||
transaction | OCGN | Common Stock | Sale | -$8.24K | -4.5K | -100% | $1.83 | 0 | Oct 6, 2022 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OCGN | Option (Right to Buy) | Options Exercise | $0 | -4.5K | -50% | $0.00 | 4.5K | Oct 6, 2022 | Common Stock | 4.5K | $0.51 | Direct | F2 |
Id | Content |
---|---|
F1 | This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
F2 | The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal monthly installments over three years commencing on February 2, 2020, subject to continued service with Ocugen, Inc. on the applicable vesting dates. |
Exhibit List: Exhibit 24.1 - Power of Attorney